This requires Flash to play. Click here to download.
MERCK

The information on this site is intended for healthcare professionals in the United States and is not intended for the general public.

I AM A HEALTHCARE PROFESSIONAL I AM NOT A HEALTHCARE PROFESSIONAL
Zolinza® [vorinostat] capsules Reactivate Expression
Home About ZOLINZA Efficacy Safety Profile Dosage Reimbursement Physician Resources Patient Education CTCL Overview Prescribing Information Patient Product Information
Patient Product Information

Physician Resources: Downloads

Preview and/or download the following resources.

Slide Kit About ZOLINZA

Slide Kit About ZOLINZA
Download or view a slide kit about the mechanism of action, efficacy, safety, and dosage of ZOLINZA, and product access.

Prescribing Information

Prescribing Information
Read the Prescribing Information for ZOLINZA.

MECHANISM OF ACTION OF ZOLINZA

MECHANISM OF ACTION OF ZOLINZA
Click here to watch the mechanism of action video about HDAC & the effects on cancer.

Platform Requirements:

  • Windows 95 or later
  • Power Macintosh OS 7.5 or later

Software Requirements:

  • Microsoft PowerPoint 97 or later

System Requirements:

For PC:
  • Pentium Processor 300 MHz or better
  • 128 MB RAM
  • Windows 2000 or above
  • Display 800 x 600 pixels 16-bit color
For MAC:
  • G4 500 MHz
  • 128 MB RAM (256 RMA with OS X)
  • OX10.1.5 or greater
  • Display 800 x 600 pixels 16-bit color

Additional Resources

Medical Society Links Internet Resources


Home | Patient Product Information | Prescribing Information
ZOLINZA is a registered trademark of Merck & Co., Inc. Copyright © 2008 Merck & Co., Inc. All rights reserved.

This site is intended only for healthcare professionals of the United States, its territories, and Puerto Rico.

20750170(5)-09/07-ZOL
For general information and other services for physicians
MERCK MEDICUSMERCK SOURCEMERCKServices
MerckMedicus, MerckSource, and MerckServices are trademarks of Merck & Co., Inc.